diabetestalk.net

Amlodipine Diabetes

Antihypertensive And Metabolic Effects Of Amlodipine In Patients With Non-insulin-dependent Diabetes Mellitus

Antihypertensive And Metabolic Effects Of Amlodipine In Patients With Non-insulin-dependent Diabetes Mellitus

Antihypertensive and Metabolic Effects of Amlodipine in Patients with Non-Insulin-Dependent Diabetes Mellitus The aim of this study was to evaluate the antihypertensive efficacy and possible effects on metabolic control of amlodipine in hypertensive diabetic patients. After a washout period of 4 weeks, 28 ambulatory patients with mild essential hypertension and non-insulin-dependent diabetes mellitus received amlodipine 10mg once daily for 12 weeks. Blood pressure was significantly decreased after 2,4,8 and 12 weeks of treatment when compared with basal values. No significant changes in heart rate occurred. A significant decrease in fasting plasma glucose was evident after 12 weeks. A slight but not significant decrease in pre- and postprandial plasma glucose, glycosuria and fructosamine concentrations occurred after 4 and 12 weeks of treatment. Microalbuminuria decreased significantly at the end of the study. No correlation was found between the reduction in microalbuminuria and the reduction in systolic or diastolic blood pressure. Cholesterol concentrations and triglycerides decreased, although only the latter was significant. The results of this study confirm the antihypertensive efficacy of amlodipine in hypertensive diabetic patients, and suggest a favourable influence of this drug on glycaemic and lipid control. The favourable changes in microalbuminuria observed after treatment need further studies to elucidate both the exact mechanisms behind increased microalbuminuria in the hypertensive diabetic state and the factors involved in the reduction. Adis International LimitedCalcium AntagonistAmlodipineInsulin ReleaseNicardipine These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning Continue reading >>

Antihypertensive Medications And Blood Sugar: Theories And Implications

Antihypertensive Medications And Blood Sugar: Theories And Implications

Go to: MECHANISMS OF ADVERSE GLYCEMIC EFFECTS Various theories about the mechanisms of antihypertensive-induced glycemic defects have been postulated. Few of these theories have been confirmed and some are conflicting. In general, postulated mechanisms can be classified into four categories: effects on peripheral blood flow, effects on the insulin receptor, effects on the liver and effects on insulin release (Figure 1). Improved peripheral blood flow to skeletal muscles is thought to facilitate glucose disposal to the tissues. In this way, medications such as alpha-blockers, which promote peripheral vasodilation, may improve insulin sensitivity and glucose uptake (20). Through the same mechanism, ACEIs or ARBs may improve insulin sensitivity by reducing angiotensin II-mediated vasoconstriction and/or increasing vasodilators such as bradykinin, prostaglandins or nitric oxide (21,22). Conversely, medications that reduce peripheral blood flow could direct blood away from sites of glucose uptake, reducing glucose disposal (20). Nonselective beta-blockers limit peripheral blood flow by reducing cardiac output, a beta-1-mediated effect, and preventing peripheral vasodilation, a beta-2-mediated effect (20,23). Beta-blockers with intrinsic sympathomimetic activity are less likely than nonselective agents to reduce peripheral blood flow because of neutral or stimulatory effects on beta-2 receptors (20,23). Therefore, these agents may have a reduced impact on glucose disposal and insulin sensitivity compared with nonselective beta-blockers. Cardioselective beta-blockers are also less likely to reduce peripheral blood flow than nonselective agents; however, cardioselective beta-blockers still exhibit some glycemic adverse effects (23). In support of the blood flow hypothesis is th Continue reading >>

Adht: Amlodipine Diabetic Hypertension Efficacy Response Evaluation Trial

Adht: Amlodipine Diabetic Hypertension Efficacy Response Evaluation Trial

ADHT: Amlodipine Diabetic Hypertension Efficacy Response Evaluation Trial Authors: Linda Brookes, MSc Faculty and Disclosures Presenter: Joel M Neutel, MD (Orange County Heart Institute and Research Center, Orange, California) Diabetic patients have a better chance of controlling their blood pressure with a combination of an angiotensin converting enzyme (ACE) inhibitor or an angiotensin receptor blocker (ARB) and a calcium channel blocker (CCB), according to the results of the Amlodipine Diabetic Hypertension Efficacy Response Evaluation Trial (ADHT). [1] Adding a second drug, in this case the CCB amlodipine, to monotherapy with an ACE inhibitor or an ARB more than doubled the control rate in diabetic hypertensive patients in this study. The study "confirms that the use of combination therapy is critically important in the management of hypertension -- when you do it, you need to do it early and more aggressively," Dr. Neutel said. Diabetic patients with elevated blood pressure are at greater risk of cardiovascular disease than patients without diabetes, yet most diabetic patients treated for hypertension do not achieve blood pressure goals set out by current US guidelines. [2-4] Although tight blood pressure control in diabetic patients confers even more protection than glycemic control, < 20% of these patients achieve blood pressure levels of 130/80 mm Hg. Another factor is "therapeutic inertia," with surveys showing too many physicians accepting inadequate control, even after treatment, in these patients. Aggressive blood pressure treatment is important in these patients, and addition of a second, complementary antihypertensive drug will always be more successful in lowering blood pressure than uptitrating the first drug. "We are dealing with multifactorial disease Continue reading >>

Drugs That Can Worsen Diabetes Control

Drugs That Can Worsen Diabetes Control

One of the main goals of any diabetes control regimen is keeping blood glucose levels in the near-normal range. The cornerstones of most plans to achieve that goal include following a healthy diet, getting regular exercise, and taking insulin or other medicines as necessary. However, it’s not uncommon for people with diabetes to have other medical conditions that also require taking medicines, and sometimes these drugs can interfere with efforts to control blood glucose. A few medicines, including some commonly prescribed to treat high blood pressure and heart disease, have even been implicated as the cause of some cases of diabetes. This article lists some of the medicines that can worsen blood glucose control, the reasons they have that effect, the usual magnitude of the blood glucose changes, as well as the pros and cons of using these drugs in people who have diabetes. Where the problems occur To understand how various medicines can worsen blood glucose control, it helps to understand how insulin, the hormone responsible for lowering blood glucose, works in the body. Insulin is released from the beta cells of the pancreas in response to rising levels of glucose in the bloodstream, rising levels of a hormone called GLP-1 (which is released from the intestines in response to glucose), and signals from the nerve connections to the pancreas. The secretion of insulin occurs in two phases: a rapid first phase and a delayed second phase. Both of these phases are dependent on levels of potassium and calcium in the pancreas. Insulin acts on three major organs: the liver, the muscles, and fat tissue. In the liver, insulin enhances the uptake of glucose and prevents the liver from forming new glucose, which it normally does to maintain fasting glucose levels. In muscle and f Continue reading >>

Controlling Hypertension In Patients With Diabetes

Controlling Hypertension In Patients With Diabetes

Hypertension and diabetes mellitus are common diseases in the United States. Patients with diabetes have a much higher rate of hypertension than would be expected in the general population. Regardless of the antihypertensive agent used, a reduction in blood pressure helps to prevent diabetic complications. Barring contraindications, angiotensin-converting enzyme inhibitors are considered first-line therapy in patients with diabetes and hypertension because of their well-established renal protective effects. Calcium channel blockers, low-dose diuretics, beta blockers, and alpha blockers have also been studied in this group. Most diabetic patients with hypertension require combination therapy to achieve optimal blood pressure goals. Nearly one in four adults in the United States has hypertension, and more than 10 million adults have diabetes.1 Moreover, hypertension is twice as common in persons with diabetes as it is in others.2 Obesity may be a common link between the two disorders, but other factors such as insulin resistance3 and autonomic dysfunction4 may also be involved. Excess weight with truncal obesity, hypertension, impaired glucose tolerance, insulin resistance, and dyslipidemia are among the components of the metabolic syndrome, which has been associated with an increased risk of coronary heart disease.5 In general, only 25 percent of patients with hypertension have adequate control of their blood pressure.6 Blood pressure goals are lower, and thus more difficult to achieve, in patients who also have diabetes. Elevated blood pressure is known to contribute to diabetic microvascular and macrovascular complications (Table 1).4,7,8 Fortunately, reductions in blood pressure can decrease the risk of these complications.8 TABLE 1 Microvascular complications Renal d Continue reading >>

Amlodipine And Blood Sugars

Amlodipine And Blood Sugars

Diabetes Forum The Global Diabetes Community This site uses cookies. By continuing to use this site, you are agreeing to our use of cookies. Learn More. Get the Diabetes Forum App for your phone - available on iOS and Android . Find support, ask questions and share your experiences. Join the community Rachox Type 2 (in remission!) Moderator I have been on Amlodipine and Ramipril for a number of years for my blood pressure. Since being diagnosed Type 2, going low carb and loosing a chunk of weight my BP had come down to the point when I was getting dizzy if I stood up quickly. After a week of home monitoring with an average BP of 124/77 my GP agreed I could stop the Amlodipine. That was three weeks ago. I have been monitoring my BP every day and since stopping it my BP is averaging 127/77 so just a tiny rise. However the main point of this post is that Id read that Amlodipine can raise blood sugars in Type 2s. I never knew if that was true for me as I was on Amlodipine before my type 2 diagnosis. That was why I wanted to drop the Amlodipine rather than the Ramipril, plus Ramipril has kidney protecting qualities. Anyway my average blood sugars are down, so far March is showing an average of 5.4 down from Februarys 5.5 and were only half way through March! Several times a week Im getting 4s now in the evenings where before 4s were a rarity! Im seeing my GP next Tuesday and am hoping I can stay off Amlodipine. Im not sure when hell want my next HbA1c but Im hoping May 3 months after my last and if my HbA1c has gone down further Im going to ask to drop one of my Metformin. I think hell agree as he said those immortal words at my last appointment that he didnt want my HbA1c to go much lower! Just thought this might be interesting to any other Type 2s on Amlodipine. Remember Continue reading >>

Diabetes And High Blood Pressure

Diabetes And High Blood Pressure

High blood pressure (hypertension) can lead to many complications of diabetes, including diabetic eye disease and kidney disease, or make them worse. Most people with diabetes will eventually have high blood pressure, along with other heart and circulation problems. Diabetes damages arteries and makes them targets for hardening, called atherosclerosis. That can cause high blood pressure, which if not treated, can lead to trouble including blood vessel damage, heart attack, and kidney failure. Compared to those with normal blood pressure readings, people with hypertension more often have: Peripheral vascular disease, hardening of the arteries in the legs and feet Even blood pressure that's at the higher end of normal (120/80 to 129/80), called elevated, impacts your health. Studies show that you have a two to three times greater chance of getting heart disease over 10 years. Readings vary, but most people with diabetes should have a blood pressure of no more than 130/80. The first, or top, number is the "systolic pressure," or the pressure in your arteries when your heart squeezes and fills the vessels with blood. The second, or bottom, number is the "diastolic pressure," or the pressure in your arteries when your heart rests between beats, filling itself with blood for the next contraction. When it comes to preventing diabetes complications, normal blood pressure is as important as good control of your blood sugar levels. Usually, high blood pressure has no symptoms. That's why you need to check your blood pressure regularly. Your doctor will probably measure it at every visit, and you may need to check it at home, too. Many of the things you do for your diabetes will also help with high blood pressure: Control your blood sugar. Don't drink a lot of alcohol. Limit how m Continue reading >>

Telmisartan In Combination With Amlodipine Provides An Effective Treatment Option For Hypertensive Patients With Diabetes: Sub-analysis From A Factorial Design Study

Telmisartan In Combination With Amlodipine Provides An Effective Treatment Option For Hypertensive Patients With Diabetes: Sub-analysis From A Factorial Design Study

Telmisartan in Combination with Amlodipine Provides an Effective Treatment Option for Hypertensive Patients with Diabetes: Sub-Analysis from a Factorial Design Study This post-hoc analysis evalua This post-hoc analysis evaluated the efficacy of telmisartan (T) + amlodipine (A) in hypertensive patients with type 2 diabetes, the co-existence of which is common and puts patients at increased cardiovascular risk, often requiring combination antihypertensive drugs to achieve the more stringent ADA BP goal of <130/80mmHg. In a double-blind, 4x4 factorial study, 1423 hypertensive patients (DBP 95119mmHg) - of whom 231 (16.2%) had diabetes - were randomized to one of 16 treatments involving T 0, 20, 40 or 80 mg and A 0, 2.5, 5 or 10 mg for 8 weeks. The combination of T+A led to clinically relevant BP reductions, and was equally effective in both hypertensive non-diabetics and diabetics. Overall, the T+A combinations were superior to the respective T and A monotherapies. With the T+A combination up to 30.4% of hypertensive diabetic patients achieved the ADA-recommended, lower BP goal of <130/80mmHg; up to 87.0% of diabetic patients at least reached BP <140/90mmHg. The greatest BP reductions and highest control rates were achieved with T80+A10. All T+A combination treatments were well tolerated. Edema rates were reduced for the T+A combinations vs A10 monotherapy. Notably, while showing lower edema rates, T+A5 combinations produced similar BP reductions to A10 in both subgroups. All T+A combinations were highly effective in hypertensive patients with diabetes, achieving double-digit BP reductions for both in-clinic SBP and DBP, thus allowing a high proportion of these patients to achieve the lower ADA BP goal with a favorable side-effect profile. T. LITTLEJOHN, P. RASKIN, J. NEU Continue reading >>

Uptitrating Amlodipine Significantly Reduces Blood Pressure In Diabetic Patients With Hypertension: A Retrospective, Pooled Analysis

Uptitrating Amlodipine Significantly Reduces Blood Pressure In Diabetic Patients With Hypertension: A Retrospective, Pooled Analysis

Uptitrating amlodipine significantly reduces blood pressure in diabetic patients with hypertension: a retrospective, pooled analysis Correspondence: Barrett W Jeffers, Pfizer Inc., 235 East 42nd Street, New York, NY 10017, USA, Tel +1 908 901 7231, Email [email protected] Author information Copyright and License information Disclaimer Copyright 2014 Jeffers et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution Non Commercial (unported, v3.0) License The full terms of the License are available at . Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Diabetic patients with hypertension are approximately twice as likely to develop cardiovascular disease as non-diabetic patients with hypertension. Given that hypertension affects 60% of patients with diabetes, effective blood pressure (BP) management is important in this high-risk population. This post-hoc analysis pooled data from six clinical studies to quantify additional BP efficacy achieved when titrating hypertensive diabetic patients from amlodipine 5 mg to 10 mg. Approximately half of the diabetic patients were male (44/98; 44.9%) with a mean (standard deviation [SD]) age of 60.6 (9.6) years and a baseline mean (standard error [SE]) systolic blood pressure/diastolic blood pressure (SBP/DBP) of 150.8 (1.30)/87.5 (0.94) mmHg while on amlodipine 5 mg (159.1 [1.40]/92.6 [0.94] mmHg prior to treatment). In comparison, 350/610 (57.4%) non-diabetic patients were male with a mean (SD) age of 58.7 (11.1) years and baseline mean (SE) SBP/DBP of 150.3 (0.62)/90.9 (0.41) mmHg while on amlodipine 5 mg (160.0 [0.67]/96.2 [0.45] mmHg prior to treatment). Increasing amlo Continue reading >>

The Effect Of Amlodipine On Blood Glucose Level And Its Interaction With Oral Hypoglycemic Drugs In Albino Rabbits - Scopemed.org - Deposit For Medical Articles

The Effect Of Amlodipine On Blood Glucose Level And Its Interaction With Oral Hypoglycemic Drugs In Albino Rabbits - Scopemed.org - Deposit For Medical Articles

The effect of amlodipine on blood glucose level and its interaction with oral hypoglycemic drugs in albino rabbits Rajeev Prajapat, I. P. Jain, S. P. Singh, Suresh Singh, Pooja Agarwal. Background: Amlodipine used as many cardiac conditions esp in hypertension. Diabetes affects cardiovascular system adversely. So this study was done to see effect of amlodipine on blood glucose level and its interaction with commonly used oral hypoglycemic agents in diabetic & non diabetic albino rabbits. Methods: Rabbits were divided into nine groups of 6 rabbits in each group. I and II group were non-diabetic given normal saline and amlodipine respectively. Group III to IX were made diabetic by using alloxan monohydrate (150mg/kg i.p.) & given normal saline, glimepiride, metformin, pioglitazone, amlodipine + glimepiride, amlodipine + metformin and amlodipine + pioglitazone respectively. All drugs were given orally once daily for 7 day except group VII, VIII and IX in which glimepiride, metformin and pioglitazone were added on 7th day. After GTT blood glucose level were measured at 0, 1, 2 and 6 hours on 7th day in all groups by using spectrophotometer. Results: After 7 days of treatment the amlodipine produced significant hyperglycemia in normal rabbits. Amlodipine on combination, causes significant decreased in hypoglycemic effect of glimepiride, significant increased the hypoglycemic effect of metformin, while no significant changes in hypoglycemic effects of pioglitazone in diabetic rabbits. Conclusion: The present study shows that amlodipine causes hyperglycemia in normal rabbits. Amlodipine significantly altered hypoglycemic effect of glimepiride and metformin as compared to control group. If these finding are true to human beings then amlodipine should be use cautiously in diabe Continue reading >>

Blood Glucose & Amlodipine

Blood Glucose & Amlodipine

Amlodipine, sold under the brand name Norvasc, belongs to a class of medications called calcium channel blockers. Amlodipine is mainly used to treat high blood pressure and angina caused by coronary heart disease. Amlodipine relaxes blood vessels so the heart does not have to pump as hard. Amlodipine also increases blood flow to the heart, which relieves chest pain. Amlodipine might affect blood glucose levels. Video of the Day Amlodipine might cause hyperglycemia, or increased blood glucose levels, according to Drugs.com. Glucose is the main source of energy for the body.The body produces glucose from the breakdown of carbohydrates, fats and proteins. High levels of blood glucose can cause damage to blood vessels and body organs. Insulin, a hormone produced by the pancreas, helps the body control blood glucose levels. Healthy people are able to lower high blood glucose levels caused by amlodipine, but diabetics might have problems. Amlodipine should be used cautiously in patients with diabetes. Symptoms of Hyperglycemia Patients with a blood glucose level higher than 160 mg/dl are considered to have hyperglycemia. Amlodipine causes short-term hyperglycemia. Blood glucose levels return to normal when the drug is discontinued. Symptoms of hyperglycemia caused by amlodipine include increased thirst, frequent urination, increased hunger, blurred vision, fatigue and dry mouth. Chronic hyperglycemia is common in patients with diabetes. Amlodipine is available as an oral tablet that is taken once daily. Amlodipine should be taken around the same time each day. Diabetics should check their blood glucose levels before and after taking amlodipine. Patients taking amlodipine should be aware of the signs of hyperglycemia and report them to their doctor. Patients taking amlodipine Continue reading >>

The Effect Of Amlodipine And Lisinopril On Retinal Autoregulation In Type 1 Diabetes

The Effect Of Amlodipine And Lisinopril On Retinal Autoregulation In Type 1 Diabetes

You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. The Effect of Amlodipine and Lisinopril on Retinal Autoregulation in Type 1 Diabetes The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. ClinicalTrials.gov Identifier: NCT00337298 Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information The purpose of this study is to compare the effect of two antihypertensive drugs on retinal vessel diameter in young type 1 diabetics. The retinal vessel analyzer (RVA) was used to investigate how the drugs affected vessel diameter, when the subjects were exposed to an increase in blood pressure, induced by isometric muscle contraction and when they were stimulated by flickering light. Type 1 Diabetes Diabetic Retinopathy Eye Diseases Diabetes Complications Diabetes is a leading cause of blindness in the western part of the world. Diabetic patients develop diabetic retinopathy which can progress to blindness. Diabetic retinopathy is associated with an increase of blood flow in the retinal vessels, ischaemia in the periphery and macular oedema. It has been shown in previous trials, that the pressure and metabolic autoregulation is disturbed in patients with diabetes, and it is believed to contribute to the development of diabetic retinopathy. In healthy subjects the retinal arterioles will contract during an increase in blood pressure, but trials have shown that this response is impaired in diabetics. When the retina is exposed to flickering lights, the metabolism inc Continue reading >>

Study Of Effect Of Amlodipine On Blood Sugar Level

Study Of Effect Of Amlodipine On Blood Sugar Level

Nepal Journals OnLine (NepJOL) is a service to provide access to Nepalese published research, and increase worldwide knowledge of indigenous scholarship. Read more . Study of Effect of Amlodipine on Blood Sugar Level Objective: To study the effect of AMLODIPINE on blood sugarlevels in hypertensive patients. Method: It is a prospective study in which patients were selected from Princess Esra hospital, Hyderabad. Results: This study was done on 20 mild to moderate newly detected hypertensive patients. Statistical analysis shows a highly significant rise in blood sugar level with P' value < 0.001 after 2 and 4 weeks of using 2.5 to 5 mgm (once daily) amlodipine. Conclusion: As calcium channels are involved in the release of insulin from the cells of pancreas, calcium channel blockers like amlodipine may cause hyperglycemia when used in hypertensive patients. Further studies are required in this field on a larger number of patients. Keywords: Amlodipine; Calcium channel blockers; Diabetes Mellitus; Hypertension Asian Journal of Medical Sciences Vol.1(1) 2010 p.4-5 Amlodipine; Calcium channel blockers; Diabetes Mellitus; Hypertension Continue reading >>

The Effect Of Amlodipine On Blood Glucose Level And Its Interaction With Oral Hypoglycemic Drugs In Albino Rabbits | Prajapat | International Journal Of Basic & Clinical Pharmacology

The Effect Of Amlodipine On Blood Glucose Level And Its Interaction With Oral Hypoglycemic Drugs In Albino Rabbits | Prajapat | International Journal Of Basic & Clinical Pharmacology

The effect of amlodipine on blood glucose level and its interaction with oral hypoglycemic drugs in albino rabbits Rajeev Prajapat, I. P. Jain, S. P. Singh, Suresh Singh, Pooja Agarwal Background: Amlodipine used as many cardiac conditions esp in hypertension. Diabetes affects cardiovascular system adversely. So this study was done to see effect of amlodipine on blood glucose level and its interaction with commonly used oral hypoglycemic agents in diabetic & non diabetic albino rabbits. Methods: Rabbits were divided into nine groups of 6 rabbits in each group. I and II group were non-diabetic given normal saline and amlodipine respectively. Group III to IX were made diabetic by using alloxan monohydrate (150mg/kg i.p.) & given normal saline, glimepiride, metformin, pioglitazone, amlodipine + glimepiride, amlodipine + metformin and amlodipine + pioglitazone respectively. All drugs were given orally once daily for 7 day except group VII, VIII and IX in which glimepiride, metformin and pioglitazone were added on 7th day. After GTT blood glucose level were measured at 0, 1, 2 and 6 hours on 7th day in all groups by using spectrophotometer. Results: After 7 days of treatment the amlodipine produced significant hyperglycemia in normal rabbits. Amlodipine on combination, causes significant decreased in hypoglycemic effect of glimepiride, significant increased the hypoglycemic effect of metformin, while no significant changes in hypoglycemic effects of pioglitazone in diabetic rabbits. Conclusion: The present study shows that amlodipine causes hyperglycemia in normal rabbits. Amlodipine significantly altered hypoglycemic effect of glimepiride and metformin as compared to control group. If these finding are true to human beings then amlodipine should be use cautiously in diabet Continue reading >>

What Medicines Can Make Your Blood Sugar Spike?

What Medicines Can Make Your Blood Sugar Spike?

If you have diabetes or high blood sugar, you probably know some of the things that cause your glucose (another name for blood sugar) to go up. Like a meal with too many carbohydrates, or not enough exercise. But other medicines you might take to keep yourself healthy can cause a spike, too. Know Your Meds Medicines you get with a prescription and some that you buy over the counter (OTC) can be a problem for people who need to control their blood sugar. Prescription medicines that can raise your glucose include: Steroids (also called corticosteroids). They treat diseases caused by inflammation, like rheumatoid arthritis, lupus, and allergies. Common steroids include hydrocortisone and prednisone. But steroid creams (for a rash) or inhalers (for asthma) aren’t a problem. Drugs that treat high blood pressure, such as beta-blockers and thiazide diuretics High doses of asthma medicines, or drugs that you inject for asthma treatment OTC medicines that can raise your blood sugar include: Cough syrup. Ask your doctor if you should take regular or sugar-free. How Do You Decide What to Take? Even though these medicines can raise your blood sugar, it doesn’t mean that you shouldn’t take them if you need them. The most important thing is to work with your doctor on the right way to use them. If you have diabetes or you’re watching your blood sugar, ask your doctor before you take new medicines or change any medicines, even if it’s just something for a cough or cold. (Remember, just being sick can raise your blood sugar.) Make sure your doctor knows all the medicines you take -- for diabetes or any other reason. If one of them may affect your blood sugar, she may prescribe a lower dose or tell you to take the medicine for a shorter time. You may need to check your blood s Continue reading >>

More in diabetes